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Medical Marijuana and the Healthcare System
Abstract: Many individuals in America suffer from chronic 
diseases (Glaucoma, Cancer, PTSD, HIV/AIDS, and 
multiple sclerosis) and medical marijuana can alleviate the 
side effects associated with these conditions. The federal 
government should legalize marijuana in order to give 
individuals with chronic diseases the organic medication 
they need to manage their symptoms. The current literature 
discusses how this topic is a national and community 
healthcare issue due to the large numbers of individuals with 
chronic conditions who could benefit from access to medical 
marijuana. Medical marijuana has the ability to improve the 
cost, access, and quality of healthcare in the United States 
for persons living with chronic diseases. This paper explores 
how cannabis impacts the delivery of healthcare as well 
as populations who are impacted. Additionally, this paper 
explores how this topic applies to occupational science, the 
future role of healthcare providers, and current healthcare 
policies.
Keywords: Medical Marijuana, Medical Cannabis, 
healthcare, occupational science
 Medical marijuana is an herbal drug that has existed for thousands 
of years and is used to help manage certain health issues. Historically, 
cannabis dates back as far as 12,000 years and is among the oldest 
cultivated crops with its roots beginning in central Asia (Warf, 2014). 
Based on carbon-14 dating, the first documented use of medical marijuana 
was for Chinese Emperor Shen Nung in 2737 BC as an anesthetic during 
surgery (Warf, 2014). It was also used in ancient China for rope, clothing, 
sails, and bowstrings. Currently, medical marijuana is illegal by the federal 
government and any state allowing its use for medical purposes is breaking 
federal law. Based on research and individual testimonies, marijuana ranks 
high in its medicinal purposes. It benefits those suffering from Aids/HIV, 
Glaucoma, multiple sclerosis, cancer, post traumatic stress syndrome, and 
many more medical conditions (Thompson, 2016; Vargo, 2016). Medical 
marijuana is an important potential medication because it has low side-
effects compared to other medications used to treat these conditions (Grant, 
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Atkinson, & Gouaux, 2012). This article will be investigating how medical 
marijuana is used today and how it affects the healthcare system.
Methods
 
 The purpose of this research project was to find scholarly articles 
related to medical marijuana to analyze this topic in relation to current 
legislation, healthcare policies, and occupational science concepts, as well 
to identify the populations most impacted by lack of access to medical 
marijuana. The method of this project included an extensive search of the 
literature through the following scholarly databases such as Academic 
Search Complete, Google Scholar, and PubMed. Additionally, newspapers, 
textbooks, and national magazines were also searched for relevant 
information related to the topic. The following main keywords were used 
in the literature search process: Medical cannabis, medical marijuana, 
cancer, glaucoma, AIDS/HIV, multiple sclerosis, PTSD, Marijuana policy, 
marijuana litigation, occupational marginalization.
National and Community Healthcare Issue
 Medical marijuana is a national and community healthcare issue 
because nationally it is classified by the federal government as a schedule 
1 narcotic; thus, categorizing it as an illegal substance with no “medical 
value.” Because marijuana is a Schedule 1 narcotic, its possession and sale 
are subject to the most severe criminal penalties (Titus, 2016). Some states 
have legalized medical marijuana, but because its use is a federal crime, 
insurance companies will not cover the cost of this medication (Luthra, 
2016).
 Nationally, many people suffer from chronic diseases of which 
marijuana can alleviate side-effects. A recent article tells the story of how 
marijuana helped a US Army infantryman wean off many high side effect 
medications. He was able to replace as many as 150 medications a day with 
medical marijuana (Thompson, 2016). In addition, marijuana has little to 
no harmful side-effects and is essentially non-addictive. Marijuana use can 
not be fatal and no deaths have ever been reported from marijuana overdose 
(Vargo, 2016). 
 As far as being a community (Kentucky) healthcare issue, marijuana 
is currently illegal in this state. Kentucky also has high rates of opiate 
overdose and drug abuse. Medical marijuana is a community healthcare 
issue because it can be used to treat the same conditions that opiates are 
“treating” without the fear of addiction or overdosing. In 2015, Kentucky 
had 1,248 overdose deaths, but it is expected that the number will increase 
as more reports are available for calculation (Estep, 2016). Research shows 
that medical marijuana can be useful in the treatment of pain, making it a 
potentially suitable alternative to opioids for some individuals (Thompson, 
2016). If marijuana instead of opiates were being prescribed to individuals 
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with chronic pain, this overdose rate would go down because one can not 
overdose on marijuana. Doctors take patients off of opiates after a period 
of use and this results in a potential heroin user because it is cheaper to buy 
heroin on the street than it is to purchase an opiate (Narconon International, 
2016).
How Marijuana Impacts the Delivery of Healthcare
 Medical marijuana impacts the delivery of healthcare because it 
changes and will continue to change the way pharmacists perform their job. 
A recent pharmaceutical publication suggested that pharmacists need to 
understand the legal framework surrounding medical marijuana so they can 
protect themselves and better serve their patients (Seamon, 2007). Pharmacy 
schools are already considering and planning how they will incorporate 
medical marijuana into the curriculum if it becomes legalized nationally. A 
study examining pharmacy student’s attitudes on marijuana explained that 
if this medication becomes legal, students will need education and training 
to address its safe and effective use (Moeller & Woods, 2015).
 Furthermore, marijuana impacts the delivery of healthcare because 
it changes and will continue to change the way doctors do their job. In 
states that have legalized marijuana, doctors are already “recommending” 
marijuana to their patients. “In 2002, the Ninth Circuit affirmed the grant 
of an injunction barring the federal government from punishing physicians 
who recommend marijuana to their patients for medical use in Conant v. 
Walters” (Mccarthy, 2004, p. 333). Doctors no longer fear being punished 
for recommending marijuana. However, in the states that do allow the 
use of medical cannabis, doctors are not allowed to prescribe it, they can 
only recommend its use (Marcoux, Larrat, & Vogenberg, 2013). Until the 
federal government legalizes medical marijuana doctors will not be allowed 
to formally “prescribe” it in the traditional manner needed for insurance 
coverage. Currently, insurance companies do not cover medicinal marijuana.
 Medical marijuana has also impacted the delivery of healthcare 
by creating collaboration between physicians and marijuana dispensaries, 
adding a new specialty area to doctors’ resume. Doctors are collaborating 
with dispensaries and other clinicians to utilize their specialized knowledge 
on the best strains of marijuana for the particular condition, safest 
administration route, and lowest effective dose (Metts, Wright, Sundaram, 
& Hashemi, 2016). Legalizing marijuana will impact health care providers 
(doctors/pharmacist) by allowing them to legally provide at times the best 
and safest care through an additional medical route.
Population Impacted and in What Ways
 
 The population that will be impacted by the legalization of medical 
marijuana will be individuals suffering with chronic diseases such as 
glaucoma, cancer, HIV/AIDs, PTSD, and MS. Hospice health professionals 
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were assessed in a survey and approximately 90% supported legalization 
of marijuana (Uritsky, McPherson, & Pradel, 2011). With large support 
from Hospice, which specializes in chronic condition management, this 
reflects professional support that medical marijuana can positively impact 
individuals with chronic conditions. 
 Medical marijuana impacts individuals with glaucoma by reducing 
the intraocular pressure associated with this condition (Chapkins, 2007). 
The intraocular pressure is the fluid pressure inside of the eye that builds up 
over time. This can cause pain and also lead to cranial nerve II (optic nerve) 
damage, which can result in blindness. Cannabis also impacts individuals 
with AIDS/HIV who experience appetite loss. Trials in AIDS patients with 
clinically significant weight loss indicated that dronabinol significantly 
outperformed a placebo in terms of appetite enhancement (Grant, Atkinson, 
& Gouaux, 2012). Dronabinol is essentially tetrahydrocannabinol (pill 
form), which is a byproduct derived from marijuana. In addition, a systematic 
review and meta-analysis found evidence suggesting that cannabinoids like 
dronabinol and others were associated with weight gain in patients with 
HIV/AIDs (Metts, Wright, Sundaram, & Hashemi). 
 Individuals with cancer are also highly impacted by medical 
marijuana. Marijuana is known to stimulate appetite, making its use in 
reducing che¬motherapy-associated nausea and vomiting wide¬ spread. 
(Vargo, 2016). Medical cannabis also alleviates the chronic pain associated 
with chemotherapy and helps prevent chemo induced anorexia associated 
with the loss of appetite. Despite the variation in state laws regard¬ing 
the conditions approved to use medical marijuana, cancer is included as 
a qualifying illness in every state that allows it (Vargo, 2016). Essentially, 
marijuana is commonly believed to alleviate the side-effects associated with 
cancer, given its access in all states that have it legalized. 
 Marijuana also impacts individuals with PTSD. A recent study 
showed that patients who smoked cannabis saw a 75 percent reduction in 
PTSD symptoms (“State Approves PTSD for Medical Marijuana”, 2016). 
According to the Veterans Administration, nearly 30 percent of veterans who 
served in the Iraq and Afghanistan wars suffer from PTSD (State Approves 
PTSD for Medical Marijuana, 2016). The federal government estimates that 
500,000 of the 2.7 million troops who served in those wars may have the 
condition (Thompson, 2016). Marijuana reduces PTSD symptoms such as 
but not limited to anxiety, flashbacks, and depression (Thompson, 2016). 
Medicinal marijuana has strong potential to make a positive impact on the 
lives of those suffering from PTSD.
 Cannabis also impacts individuals with multiple sclerosis by 
relieving chronic neuropathic pain and spasticity (Vargo, 2016). In addition 
to this, “a 2015 systematic review and meta-analysis found moderate quality 
evidence to support its use for the treatment of chronic and neuropathic 
pain and spasticity associated with multiple sclerosis” (Metts, 2016, p. 78). 
Essentially, multiple sclerosis is a progressive disease that damages the 
myelin sheaths in the brain and spinal chord that can cause symptoms such 
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as numbness, impaired muscular coordination and fatigue. Marijuana can 
have a large impact on individuals with MS by alleviating the neuropathic 
pain and spasticity associated with the disease. 
 Chronic pain affects more Americans than diabetes, heart disease, 
and cancer combined with over 100 million people living with chronic pain 
(American Academy of Pain Medicine, 2017). Due to the nature of chronic 
pain, a significant portion of this population likely has reduced occupational 
performance, meaning they struggle to perform the required activities, tasks, 
and roles of everyday living. Given the amount of individuals impacted 
from pain such as those with cancer, MS, and Glaucoma, medical marijuana 
has a role in chronic pain management. Essentially, cannabis can enhance 
occupational performance in individuals who experience chronic pain 
by alleviating their discomfort and allowing them to perform without the 
burden of pain to achieve greater functional levels.
 Many individuals in America suffer from chronic diseases 
(Glaucoma, Cancer, PTSD, HIV/AIDS, and multiple sclerosis) and medical 
marijuana can alleviate the side effects associated with these conditions. The 
federal government should legalize marijuana in order to give individuals 
with chronic diseases the organic medication they need to manage their 
symptoms.
Medical Marijuana and Healthcare Principles
 The healthcare delivery system and medical marijuana are related 
through the discussion of: cost, access, and quality (Shi & Singh, 2015). 
Legalizing medical marijuana could improve those three aspects of 
healthcare. Medical marijuana is cost effective. For example, giving an HIV/
AIDS patient a prescription for medical marijuana to increase their appetite 
and reduce their nausea, vomiting, and pain would be more cost effective 
than prescribing three different medications that one medication (medical 
marijuana) can treat. Medical marijuana price varies from state to state. 
Although, Denver dispensaries charge medicinal customers around $10 per 
gram (Ross, 2014). It is difficult to compare other individual drug prices 
to medical marijuana, as many publically available drug prices provided 
online are listed at the insurance discounted rate. This same scenario and 
condition can be applied to the quality aspect of healthcare. For example, 
the AIDS/HIV patient is receiving an unjust quality of care by being placed 
on opiates for pain. They are being put at unnecessary risk for addiction and 
liver damage, among other risk. In relation to access, there is no safe access 
because the federal government can step in at any time at the state level to 
convict a medical marijuana user even in a state where it is legalized. Also, 
not all states have legalized marijuana.
How Medical Marijuana Applies to Occupational Science
 Medical marijuana applies to occupational science because the 
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federal government not allowing individuals to use this medication is 
occupational marginalization. Occupational marginalization occurs when 
individuals are oppressed by a higher power, such as the government, from 
making decisions and choices regarding their occupational participation 
(Christiansen & Townsend). Essentially, persons with chronic conditions 
and other illnesses are marginalized and have no autonomy in the occupation 
of using medical marijuana to reduce their symptoms to support function. 
The government creates restrictions, policies, and laws that prevent 
individuals with chronic diseases from fully engaging in health maintenance 
as an occupation, even with a doctor’s recommendation. Individuals also 
experience barriers in the occupation of growing marijuana, which could 
be experienced as a relaxing occupation to promote restoration while 
living with a debilitating and stressful disease. Clients may not be able to 
complete other valued occupations, such as work and leisure task, because 
the symptoms associated with their condition are not alleviated due to lack 
of access. 
 Kielhofner (2008) describes volition as “pattern of thoughts and 
feelings about one-self as an actor in one’s world which occur as one 
anticipates, chooses, experiences, and interprets what one does” (p. 47). How 
one takes care of oneself, decides their health treatment plan, and lives their 
life are aspects of one’s volition. Many individuals with chronic conditions 
value and have interest in medical marijuana because it is an organic and low 
side-effect treatment option for their condition. Having more options and 
autonomy related to medications for symptom management would increase 
a client’s volition by giving them choice in their treatment to support their 
health.
Application as A Future Healthcare Provider
 Medical marijuana applies to the future role as a healthcare provider 
because one could potentially encounter a patient prescribed medical 
marijuana. This topic is important because as a future health care provider, 
it is one’s responsibility to ensure that the patient gets the best quality of 
therapy out of every session. Therefore, if a client is suffering from chronic 
pain, the provider could advise nursing to administer their medical marijuana 
30 minutes before the therapist arrives to ensure the client is not suffering 
from pain during the therapy session. This is a common practice in acute 
care therapy, in which the nurse will give patients pain medication before 
rehabilitation staff provide care to the individual. As a healthcare provider, 
it is also one’s responsibility to counsel the patient about safety. If an OT 
is providing an intervention to a patient to help them establish a weekly 
medication routine, they could read the pharmacist’s recommendations and 
medication side-effects and make a sign in the medicine cabinet to remind 
the patient about contraindications. The therapist could also be an advocate 
for the patient by attending local and national legislative events to promote 
the medical benefits of marijuana. 
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 Occupational therapists are seeing more patients with chronic pain 
in their daily practice. OTs need to stay informed of the techniques doctors 
are using with patients to alleviate pain, including prescription marijuana 
(Karplus, 2014). As a future healthcare provider, it is one’s responsibility 
to stay current on medications that patients are taking, including medical 
marijuana. Occupational therapy practitioner’s have a direct role in 
chronic pain management. They help identify, teach, implement, facilitate, 
collaborate, and recommend chronic pain management strategies to clients 
(AOTA, 2016). This is why it is paramount that OTs be informed about 
medical marijuana.
Relevance of Medical Marijuana to Current Healthcare Policies
 Medical marijuana is relevant to current healthcare policies because 
it is a healthcare policy movement that has been gaining a large amount of 
attention in the United States. Nationally, federal laws prohibit medical and 
recreational marijuana. At the state level, it is only legal in 26 states. All 
states that have medical marijuana have approved it for cancer care (Vargo, 
2016). This is the only condition in which all states allow a mutual access to 
medical marijuana. States vary on the approval for other conditions such as 
AIDS/HIV, glaucoma, MS, and PTSD. However, the policies in most states 
allow all of these. 
 Medical marijuana is a schedule 1 narcotic, which is why it is illegal. 
Doctors are allowed to “recommend” it without prosecution; however, 
insurance companies do not cover medical marijuana. Recently, “the DEA 
approved the first-ever study of the use of the marijuana plant itself, not 
individual extracts, as a therapeutic drug” (Thompson, 2016, p. 36). This 
could shift current healthcare policies because if the DEA made marijuana a 
schedule 2 drug, this would put it in the category of drugs such as morphine 
and oxycodone. This would make it easier for doctors to prescribe and 
more likely that insurance companies would cover this medication (Luthra, 
2016). This would make medical marijuana accessible to individuals with 
chronic conditions.
Implications and Consequences on Healthcare Service Delivery
 The federal government should drop marijuana from a schedule 1 
narcotic to a schedule 2 narcotic so doctors can formally prescribe it instead 
of only recommending it. This process would have to be completed through 
legislation. Following the legalization from the federal government, 
insurance companies would begin to cover medical marijuana because 
it would be in the same category as morphine and oxycodone, which are 
covered by insurance companies (Luthra, 2016). One major consequence of 
legalizing medical marijuana is that doctors and pharmacists would have to 
be trained on this drug. In the beginning of legalization, the novelty of this 
medication could cause over or under prescription. Necessary education 
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on dosage, strands, and ingestion routes could be incorporated into 
pharmacy schools and medical schools during academic preparation. For 
professionals who are already practicing, they could obtain this education 
through continuing education units. Medical marijuana would also affect big 
pharmaceutical companies by decreasing the amount of other drugs being 
prescribed because marijuana has such as wide scope of practice, which 
could lower pharmaceutical company profits. In states that have already 
legalized medical marijuana, research showed a decline in the number of 
Medicare prescriptions for chronic pain, anxiety and depression. They 
also saw reductions in Medicare part D spending, which covers the cost of 
prescription medications (Luthra, 2016). Legalizing medical marijuana has 
the potential to decrease healthcare spending, while also reducing symptoms 
to improve quality of life and increase function.
Conclusion
 Medical marijuana is a schedule 1 narcotic; therefore, it is federally 
illegal, but is legal in some geographic areas at the state level. This drug has 
the potential to reduce the opiate problem in Kentucky. Medical marijuana can 
impact the delivery of healthcare because it will change the way healthcare 
providers perform their jobs, specifically physicians and pharmacists. 
Medical marijuana can be beneficial for persons with cancer, HIV/AIDS, 
MS, PTSD, and glaucoma as well as having the potential to improve cost, 
access, and quality of healthcare for these individuals. Medical marijuana 
is a drug that healthcare providers may need to become familiar with in the 
future as practicing clinicians. Medical cannabis is relevant to healthcare 
because it is already legal in 26 states and may eventually become legalized 
nationally. Marijuana should be reduced from a schedule 1 narcotic to a 
schedule 2 for federal legalization. Access to medical marijuana can reduce 
symptoms and improve quality of life for individuals with a variety of 
conditions
References
American Occupational Therapy Association. (n.d). Chronic pain. Retrieved 
from http://www.aota.org/About-Occupational-Therapy/Patients-
Clients/Health-and-Wellness/Pain.aspx
Chapkis, W. (2007). Cannabis, consciousness, and healing. Contemporary 
Justice Review, 10, 443-460. doi:10.1080/10282580701677550
Christiansen, H. C, & Townsend, A. E. (2010). Introduction to Occupation: 
The art of science of living. Upper Saddle River: NJ: Pearson 
Education.
Estep, B. (2016). Drug overdose deaths climb to record level in Kentucky 
in 2015. Lexington Herald Leader. Retrieved from http://www.
kentucky.com/news/state/article83770067.html
Grant, I., Atkinson, J. H., Gouaux, B., & Wilsey, B. (2012). Medical 
marijuana: Clearing away the smoke. The Open Journal of 
https://encompass.eku.edu/kjus/vol2/iss1/4
Kentucky Journal of Undergraduate Scholarship, Issue 2, (2018)
28
Neurology, 18-25. 
Karplus, D. (2014). Medical Marijuana and occupational therapy. 
Retrieved from http://community.advanceweb.com/blogs/ot_18/
archive/2014/09/02/medical-marijuana-and-occupational-therapy.
aspx
Kielhofner, G. (2008). Model of human occupation: theory and application. 
Baltimore, Mar: Lippincott Williams & Wilkins.
Luthra, S. (2016). After medical marijuana legalized, medicare prescriptions 
drop for many drugs. Retrieved from http://www.npr.org/sections/
health-shots/2016/07/06/484977159/after-medical-marijuana-
legalized-medicare-prescriptions-drop-for-many-drugs
Marcoux, R. M., Larrat, E. P., & Vogenberg, F. R. (2013). Medical marijuana 
and related legal aspects. Pharmacy & Therapeutics, 38, 615-619. 
Mccarthy, k. I. (2004). Conversations about medical marijuana between 
physicians and their patients. Journal of Legal Medicine, 25, 333-
349.
Metts, J., Wright, S., Sundaram, J., & Hashemi, N. (2016). Medical 
marijuana: A treatment worth trying?. Journal Of Family Practice, 
65, 178-185.
Moeller, K. E., & Woods, B. (2015). Pharmacy students’ knowledge and 
attitudes regarding medical marijuana. American Journal Of 
Pharmaceutical Education, 79, 1-8.
Narconon International. (n.d.). 5 reasons prescription addiction turns to 
heroin. Retrieved from http://www.narconon.org/blog/heroin-
addiction/5-reasons-prescription-addiction-turns-to-heroin/
Ross, P. (2014). Marijuana costs in the US: How black market, retail and 
medical pot prices compare. Retrieved from http://www.ibtimes.
com/marijuana-costs-us-how-black-market-retail-medical-pot-
prices-compare-1622362
Seamon, M. J., Fass, J. A., Maria, M., & Abu-Shraie, N. A. (2007). Medical 
marijuana and the developing role of the pharmacist. American 
Journal of Health-System Pharmacy, 64, 1037-1044. doi:10.2146/
ajhp060471
Shi, L., & Singh, D. A. (2015). Delivering health care in America: a systems 
approach (6th ed.). Burlington, MA: Jones and Bartlett Learning.
State approves PTSD to list of conditions for treatment with medical 
marijuana. (2016). Rhode Island Medical Journal, 99, 64.
The American Academy of Pain Medicine. (2017). AAPM facts and figures 
on pain. Retrieved from http://www.painmed.org/patientcenter/
facts_on_pain.aspx
Thompson, M. (2016). Post-traumatic marijuana. Time, 188, 34-37.
Titus, R. D. (2016). Puff, puff, pass . . . That law: the changing legislative 
environment of medical marijuana policy. Harvard journal on 
legislation, 53, 39-58.
Uritsky, T. J., McPherson, M. L., & Pradel, F. (2011). Assessment of 
hospice health professionals’ knowledge, views, and experience 
Published by Encompass, 2018
MEDICAL MARIJUANA 
29
with medical marijuana. Journal Of Palliative Medicine, 14, 1291-
1295. doi:10.1089/jpm.2011.0113
Vargo Cavalet, J. (2016). The highs and lows of medical marijuana. Clinician 
Reviews, 26, 40-53.
Warf, B. (2014). High points: An historical geography of cannabis. 
Geographical Review, 104, 414-438. doi:10.1111/j.1931-
0846.2014.12038.x
https://encompass.eku.edu/kjus/vol2/iss1/4
